Company Details
- Employees
- 52
- Founded
- -
- Address
- 400 Concar Dr,
- Industry
- Computer And Network Security
- Website
- https://bluerock.io
- Keywords
- Coral Gables.
- HQ
- San Mateo, California
Please complete the CAPTCHA to continue
Related company profiles:
Python-socket.io module flaw lets attackers access business servers SC Media
Bluerock Interval fund wins shareholder approval to start trading. InvestmentNews
BlueRock Begins First Human Trial of iPSC Cell Therapy for Primary Photoreceptor Diseases Applied Clinical Trials
Bluerock Value Exchange Launches $71 Million 1031 Exchange BR Diversified Industrial Portfolio 6 DST PR Newswire
Bayer-owned BlueRock lays off 50 employees, shutters Cambridge research labs Fierce Biotech
BlueRock TMS Expands North American Leadership with Appointment of Brent Wallace GlobeNewswire
BlueRock accelerates Parkinson’s disease therapy to Phase III Clinical Trials Arena
Bluerock Homes Trust: Encouraging Developments (Rating Upgrade) (NYSE:BHM) Seeking Alpha
BlueRock Therapeutics advances investigational cell therapy bemdaneprocel for treating Parkinson’s disease to registrational Phase III clinical trial Bayer
Bluerock seeks to list real estate fund with investors already heading for the exits. InvestmentNews
BlueRock acquires specialist music & entertainment advisory White Sky Consultancy.com.au
Bluerock Value Exchange Launches $37.8 Million 1031 Exchange BR Churchill Downs Multifamily DST in Pinehurst, NC PR Newswire
BlueRock Therapeutics announces publication in Nature of 18-month data from Phase 1 clinical trial for bemdaneprocel, an investigational cell therapy for Parkinson’s disease GlobeNewswire
Bluerock interval fund could trade at “substantial discount” after it lists, company says. InvestmentNews
Financial services firm BlueRock facing $3m in directors’ dismissal claims AFR
Bluerock Pays $103M for Tampa Community Multifamily Housing News
BlueRock Therapeutics and bit.bio announce collaboration and option agreement for the discovery and manufacture of regulatory T cell (Treg) based therapies Bayer
FDA approves BlueRock’s cell therapy IND for photoreceptor diseases trial Clinical Trials Arena
Bluerock Announces Shareholder Approval of Key Proposal in Connection with the Listing of the Bluerock Total Income+ Real Estate Fund on the New York Stock Exchange PR Newswire
Bluerock High Income Institutional Credit Fund Announces Q3 2025 Distribution at a 11.2% Annualized Rate Yahoo Finance
Made in Idaho: BlueRock Farm Market KIVI-TV
Bluerock High Income Institutional Credit Fund Announces Q4 2024 Distribution at a 12.2% Annualized Rate and 13.7% 2024 Total Return Yahoo Finance
Bluerock Value Exchange Fully Subscribes $66 Million Class A Multifamily DST in Tampa, Florida PR Newswire
First Parkinson’s disease patient treated in BlueRock’s GlobeNewswire
36-Month Phase I: BlueRock’s bemdaneprocel Shows Durable Safety and Motor Improvements Stock Titan
BlueRock Consulting launches the Luxury Hotel Benchmarking Report Hospitality Net
Blackstone Will Buy Bluerock Residential in $3.6bn Deal Private Equity Insights
Bayer-bought BlueRock cuts 12% of workforce across 3 sites as pipeline contracts Fierce Biotech
Bluerock Total Income+ Real Estate Fund Secures $750 Million Line of Credit with JPMorgan, RBC Capital Markets PR Newswire
Bayer subsidiary BlueRock taps Rune Labs for Parkinson's study software Fierce Biotech
BlueRock Therapeutics to incorporate wearable and invisible contactless digital health technologies from Rune Labs and Emerald Innovations in Parkinson's disease clinical trial PR Newswire
Bluerock Appoints Doug Kinney as Managing Director citybiz
Bluerock Homes Trust Completes Acquisition of Skytop Apartments TipRanks
BlueRock Therapeutics exercises exclusive option to license iPSC cell therapy candidate OpCT-001 for treating Primary Photoreceptor Diseases from FUJIFILM Cellular Dynamics and Opsis Therapeutics PR Newswire
Bluerock Therapeutics’ new cell therapy product shows promise for the treatment of Parkinson’s disease BioWorld MedTech
Fraggle Rock: 40 Years Later – “The Beast of Bluerock” ToughPigs
Fujifilm Cellular Dynamics, Opsis Therapeutics and BlueRock Therapeutics Form Agreement Contract Pharma
Bayer christens $250M cell therapy 'launch facility' in Berkeley Fierce Pharma
Blackstone affiliates to buy Bluerock REIT in $3.6 bln deal Reuters
Fortino Capital makes strategic investment in BlueRock TMS to help boost its international growth ambitions American Journal of Transportation
New Berlin site to accelerate cell therapy innovation for BlueRock Therapeutics European Pharmaceutical Review
Bluerock buys second Lane Industrial Park building in Northwest Jacksonville Jacksonville Daily Record
Bayer acquires BlueRock Therapeutics to build leading position in cell therapy PR Newswire
BlueRock Therapeutics, FUJIFILM Cellular Dynamics, and Opsis Therapeutics Enter into a Strategic R&D Alliance to Discover and Develop Cell Therapies for Eye Diseases PR Newswire
Bayer to pay $240M to buy BlueRock cell therapy joint venture Fierce Biotech
BlueRock partners with Amesto Global on US expansion services Consultancy.com.au
Already Owning 40.8% of BlueRock Therapeutics, Bayer Buys Rest of Company for $600 Million BioSpace
Dutch company BlueRock TMS onboards Fortino Capital as an investor: Here’s why Silicon Canals
Ncardia and BlueRock Therapeutics Announce Collaboration Agreement and Licensing of Process Development Technologies for the Manufacture of iPSC-derived Cardiomyocytes Business Wire
Blackstone Buying Multifamily REIT Bluerock for $3.6B The Real Deal
BlueRock Horizon Asset Management: Marcus Erikson Unveils Tech-Driven Strategy ACCESS Newswire
This startup wants to regenerate the heart and brain to keep people healthier for longer businessinsider.com
BlueRock adds Arthur Advisory as it pursues capital partner Consultancy.com.au
Ophir hops onto BlueRock’s register; expands into unlisted markets AFR
BlueRock appoints Ella Morse, Trevor Gordijn and Bevan McLeod Consultancy.com.au
Professional services biz BlueRock seeks growth capital partner AFR
Pharmaceutical company Bayer AG acquiring BlueRock Therapeutics for US$1-billion The Globe and Mail
Works at Bluerock Projects’ Tuohy Garden Apartments progressing BTR News Australia
Top 5 Undervalued Biotech Companies (October 2025) Securities.io
1 +164792XXXXX
Find emails, phones & company data instantly
Your AI prospecting assistant
0 records × $0.02 per record
Secure checkout
Total price
$0.50
Enter your payment details below to complete the download. We'll email you the CSV as soon as it's ready.
Processing your payment...
Please wait while we complete your transaction
Sign in required
Create a free account or sign in to continue downloading the full results.
Sign up for a free account. No credit card required. Up to 10 free credits.
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.